Halcinonide
-
Halcinonide
structure -
-
CAS No:
3093-35-4
-
Formula:
C24H32ClFO5
-
Chemical Name:
Halcinonide
-
Synonyms:
Pregn-4-ene-3,20-dione,21-chloro-9-fluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]-,(11β,16α)-;Pregn-4-ene-3,20-dione,21-chloro-9-fluoro-11β,16α,17-trihydroxy-,cyclic 16,17-acetal with acetone;2H-Naphth[2′,1′:4,5]indeno[1,2-d][1,3]dioxole,pregn-4-ene-3,20-dione deriv.;(11β,16α)-21-Chloro-9-fluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]pregn-4-ene-3,20-dione;Halcinonide;SQ 18566;Halog;Halciderm;Alcinonide;Adcortin;Halcimat;2205903-20-2
-
Categories:
Active Pharmaceutical Ingredients > Hormones and the Endocrine System
-
CAS No:
Description
Halcinonide (SQ-18566) is a high potency corticosteroid used topically in the treatment of certain skin conditions.
Halcinonide is an organic molecular entity. It has a role as a SMO receptor agonist.|Halcinonide is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, and is distributed as a cream and ointment. Halcinonide is marketed under the brand name Halog® by Ranbaxy Laboratories Inc. Research suggests that clobetasol propionate demonstrates superior pharmacologic efficacy in the treatment of psoriasis when compared to halcinonide.|Halcinonide is a Corticosteroid. The mechanism of action of halcinonide is as a Corticosteroid Hormone Receptor Agonist.|Halcinonide is a topical, synthetic glucocorticoid with anti-inflammatory and anti-allergic properties. Halcinonide exerts its effect by interacting with specific intracellular receptors, and the ligand-receptor complex subsequently modulates gene expressions via the typical glucocorticoid signalling pathway. This results in the synthesis of certain anti-inflammatory proteins as well as in synthesis inhibition of certain inflammatory mediators. Consequently, an overall reduction in chronic inflammation and autoimmune reactions are accomplished. (NCI05)|A glucocorticoid used topically in the treatment of DERMATITIS; ECZEMA; or PSORIASIS. It may cause skin irritation.
Halcinonide Basic Attributes
454.95900
454.96
221-439-6
SI86V6QNEG
DTXSID6045375
C47552
D - Dermatologicals
2937220000
Characteristics
72.83000
3.88930
1.31 g/cm3
264 °C (decomp)
564.3ºC at 760 mmHg
295.1ºC
1.566
Keep tightly closed. Store in a cool dry place.
LD50 i.p. in mice: 150 mg/kg (Millonig, Yiakas)
200.9 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]
Safety Information
NONH for all modes of transport
3
R63
S36
TU5010200
Xn
Stable at normal temperatures and pressures.
P280
H361
|Warning|H361 (100%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]|P201, P202, P281, P308+P313, P405, and P501|Aggregated GHS information provided by 40 companies from 3 notifications to the ECHA C&L Inventory.
Toxicity
Systemic absorption of topical corticosteroids has produced reversible hypothalamicpituitary-adrenal (HPA) axis suppression, manifestations of Cushing’s syndrome, hyperglycemia, and glucosuria in some patients. Conditions which augment systemic absorption include the application of the more potent steroids, use over large surface areas, prolonged use, and the addition of occlusive dressings.
Drug Information
Indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.|FDA Label
Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)
The precise mechanism of action of topical corticosteroids is unclear. However they possess anti-inflammatory, antipruritic, and vasoconstrictive actions. New research indicates that halcinonide activates MBP (myelin basic protein) expression via smoothened receptor activation. This finding suggests that halcinonide could be used in the treatment of multiple sclerosis therapy as an alternative to Dexamethasone or Methylprednisolone.
Alcinonide
Halcinonide Use and Manufacturing
A topical steroid. Used to treat inflammation caused by a number of conditions such as allergic reactions, eczema, and psoriasis.
Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients|Pharmaceuticals
Computed Properties
Molecular Weight:455.0
XLogP3:3.6
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:6
Rotatable Bond Count:2
Exact Mass:454.1922300
Monoisotopic Mass:454.1922300
Topological Polar Surface Area:72.8
Heavy Atom Count:31
Complexity:887
Defined Atom Stereocenter Count:8
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Drug Function and Efficacy
This product is a highly effective fluorinated and chlorinated corticosteroid with anti-inflammatory, anti-pruritic and vasoconstrictive effects. Its anti-inflammatory and antipruritic mechanism is to increase the responsiveness of β receptors to catecholamine, increase CAMP production by activating adenylate cyclase, and inhibit phosphoethylesterase to reduce CAMP destruction, resulting in an increase in cAMP concentration in cells and inhibiting the release of histamine. This product has a similar effect as dexamethasone in inhibiting the proliferation of granulomas in rats and mice.
Registered Holders
-
FARMABIOS S.P.A.
Active
Italy
-
Jinyao Pharmaceutical Co., Ltd.
Active
China
-
Hunan Yuxin Pharmaceutical Co., Ltd.
Active
China
Recommended Suppliers of Halcinonide
-
CN
5 YRS
Business licensed Certified factoryManufactory Supplier of fine chemicals,pharmaceutical materials -
CN
4 YRS
Business licensed Certified factoryManufactory Supplier of Cosmetics raw materials,Pesticide intermediate,Photoelectric material,pharmaceutical intermediates,Raw materials for food and health products,Polymer materials,Fine Chemicals,Synthetic customization -
CN
4 YRS
Business licensedTrader Supplier of Semaglutide,Tirzepatide,API,EnzymeInquiryCAS No.: 3093-35-4Grade: Pharmaceutical GradeContent: 99.5%
Learn More Other Chemicals
-
Orforglipron
2212020-52-3
-
Cevimeline hydrochloride
107220-28-0
-
1-Butanone, 1-[4-(1,1-dimethylethyl)phenyl]-4-[4-(diphenylmethoxy)-1-piperidinyl]-, (2E)-2-butenedioate (1:1)
97928-20-6
-
Timbetasin acetate Formula
1346423-89-9
-
Canagliflozin Formula
842133-18-0
-
Darifenacin Formula
133099-04-4
-
Propylthiouracil Structure
51-52-5
-
Testosterone, acetate Structure
1045-69-8
-
What is Dexamethasone acetate
1177-87-3
-
What is Nateglinide
105816-04-4